Nephrologist: Vinod K. Bansal, MD | Loyola Medicine

Vinod K. Bansal, MD, FACP,FASN (Fellow of the American Society of Nephrology,FRCPC,FAHA

Vinod K. Bansal, MD, FACP,FASN,FRCPC

Medicine

Nephrology
Professor
Medical Director, Chronic Dialysis

Languages Spoken

English, Hindi

Clinical Expertise

  • High Blood Pressure
  • Hypertension
  • Kidney (Ureteric) Stone
  • Kidney Disorder
  • Kidney Transplant
  • Nephritis
  • Nephrolithiasis
  • Peritoneal Dialysis
  • Polycystic Kidney Disease
  • Renal Disease (Kidney Disease)
  • Systemic Lupus Erythematosus
  • Vasculitis

About Dr. Bansal

Interests
Golf, Jogging, Foreign movies, Travel, Reading

Medical Education

Medical School
University of Rajasthan, India
Residency
SMS Medical College
India - Internal Medicine: General
University of Illinois at Chicago Medical Center - Internal Medicine: General
Fellowship
  • University of Colorado School of Medicine - Internal Medicine: Nephrology
  • Cedars-Sinai Medical Center - Internal Medicine: Nephrology
  • New York University Medical Center - Internal Medicine: Nephrology

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Nephrology

Research

  • Biomarkers of Endothelial Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure, McMillan, R.; Skiadopoulos, L.; Hoppensteadt, D.; Guler, N.; Bansal, V.; Parasuraman, R.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Biomarker profiling of plasma samples for various diseases utilizing RANDOX Biochip Array Technology Saluk, J.; Hoppensteadt, D.; Syed, D.; Liles, J.; Abro, S.; Walborn, A.; Bansal, V.; Fareed, J., International angiology : a journal of the International Union of Angiology
  • Biomarkers of Endothelial Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure, McMillan, R.; Skiadopoulos, L.; Hoppensteadt, D.; Guler, N.; Bansal, V.; Parasuraman, R.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
View All ResearchShow Less
  • Inflammatory and Metabolic Syndrome Biomarker Analysis of Vascular Outcomes in End-stage Renal Disease Sweigert, P. J.; Bansal, V. K.; Hoppensteadt, D. A.; Saluk, J. L.; Syed, D. A.; Fareed, J., The International journal of angiology : official publication of the International College of Angiology, Inc
  • KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), Isakova, T.; Nickolas, T. L.; Denburg, M.; Yarlagadda, S.; Weiner, D. E.; Gutierrez, O. M.; Bansal, V.; Rosas, S. E.; Nigwekar, S.; Yee, J.; Kramer, H., American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation
  • Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures Small, C.; Kramer, H. J.; Griffin, K. A.; Vellanki, K.; Leehey, D. J.; Bansal, V. K.; Markossian, T. W., BMC Nephrology
  • Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report Bansal, V. K.; Herzog, C. A.; Sarnak, M. J.; Choi, M. J.; Mehta, R.; Jaar, B. G.; Rocco, M. V.; Kramer, H., American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation
  • Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey) Bress, A. P.; Kramer, H.; Khatib, R.; Beddhu, S.; Cheung, A. K.; Hess, R.; Bansal, V. K.; Cao, G.; Yee, J.; Moran, A. E.; Durazo-Arvizu, R.; Muntner, P.; Cooper, R. S., Circulation
  • Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD Markossian, T.; Burge, N.; Ling, B.; Schneider, J.; Pacold, I.; Bansal, V.; Leehey, D.; Stroupe, K.; Chang, A.; Kramer, H., American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation
  • Effect of erythropoietin stimulating agents on vascular endothelial growth factor levels in patients with end stage renal disease Saluk, J. L.; Bansal, V.; Hoppensteadt, D.; Syed, D.; Abro, S.; Fareed, J., International angiology : a journal of the International Union of Angiology
  • Urinary incontinence and diuretic avoidance among adults with chronic kidney disease Patel, M.; Vellanki, K.; Leehey, D. J.; Bansal, V. K.; Brubaker, L.; Flanigan, R.; Koval, J.; Wadhwa, A.; Balasubramanian, N.; Sandhu, J.; Kramer, H., International Urology and Nephrology
  • Immunoenzymatic and Biochip Array Profiling of the Biomarkers of Inflammation and Hemostatic Activation Processes in ESRD Richards, J.; Bansal, V.; Iqbal, O.; Hoppensteadt, D.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Neurologic Complications of Chronic Kidney Disease Vellanki, K.; Bansal, V. K., Current neurology and neuroscience reports
  • Prevalence of metabolic syndrome in patients with end stage renal disease and relevance of biomarkers Saluk, J.; Bansal, V.; Hoppensteadt, D.; Syed, D.; Abro, S.; Fareed, J., International angiology : a journal of the International Union of Angiology
  • Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal disease Sharain, K.; Hoppensteadt, D.; Bansal, V.; Singh, A.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease Kaneva, K.; Bansal, V.; Hoppensteadt, D.; Cunanan, J.; Fareed, J., Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Upregulation of surrogate markers of inflammation and thrombogenesis in patients with ESRD: pathophysiologic and therapeutic implications. Nelson, K.; Thethi, I.; Cunanan, J.; Hoppensteadt, D.; Bajwa, R.; Fareed, J.; Bansal, V., Clinical & Applied Thrombosis/Hemostasis
  • Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin. Adiguzel, C.; Bansal, V.; Litinas, E.; Cunanan, J.; Iqbal, O.; Nelson, K.; Kannan, M.; Hoppensteadt, D.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic products. Adiguzel, C.; Jeske, W. P.; Hoppensteadt, D.; Walenga, J. M.; Bansal, V.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Contaminant in the recalled unfractionated heparin preparations: where is the problem?. Hoppensteadt, D. A.; Wahi, R.; Adiguzel, C.; Iqbal, O.; Ramacciotti, E.; Bick, R. L.; Messmore, H. L.; Bansal, V.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor. Tobu, M.; Iqbal, O.; Fareed, D.; Chatha, M.; Hoppensteadt, D.; Bansal, V.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines Beto, J. A.; Bansal, V. K., Journal of the American Dietetic Association
  • Nutrition interventions to address cardiovascular outcomes in chronic kidney disease Beto, J. A.; Bansal, V. K., Advances in Chronic Kidney Disease